BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 36759259)

  • 1. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
    Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT;
    Biol Psychiatry; 2023 May; 93(9):770-779. PubMed ID: 36759259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Proteome-Wide and Transcriptome-Wide Asso-ciation Studies, Bayesian Colocalization, and Mendelian Randomization Analyses Reveal Causal Genes of Parkinson's Disease.
    Zhou S; Tian Y; Song X; Xiong J; Cheng G
    J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):563-568. PubMed ID: 36511626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Brain Protein Abundance and Cross-tissue mRNA Expression in Amyotrophic Lateral Sclerosis.
    Ma Y; Jia T; Qin F; He Y; Han F; Zhang C
    Mol Neurobiol; 2024 Jan; 61(1):510-518. PubMed ID: 37639066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and Brain Structure in Alzheimer's Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study.
    Liu WS; Zhang YR; Ge YJ; Wang HF; Cheng W; Yu JT
    Mol Neurobiol; 2024 Mar; 61(3):1593-1604. PubMed ID: 37736795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
    Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
    PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function and neurodegenerative diseases : a two-sample Mendelian randomization study.
    Liu X; Ou YN; Ma YH; Huang LY; Zhang W; Tan L
    Neurol Res; 2023 May; 45(5):456-464. PubMed ID: 36692889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis.
    Wainberg M; Andrews SJ; Tripathy SJ
    Alzheimers Res Ther; 2023 Jun; 15(1):113. PubMed ID: 37328865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic overlap between Alzheimer's disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson's disease.
    Wightman DP; Savage JE; Tissink E; Romero C; Jansen IE; Posthuma D
    Neurobiol Aging; 2023 Jul; 127():99-112. PubMed ID: 37045620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT
    J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
    van der Lee SJ; Conway OJ; Jansen I; Carrasquillo MM; Kleineidam L; van den Akker E; Hernández I; van Eijk KR; Stringa N; Chen JA; Zettergren A; Andlauer TFM; Diez-Fairen M; Simon-Sanchez J; Lleó A; Zetterberg H; Nygaard M; Blauwendraat C; Savage JE; Mengel-From J; Moreno-Grau S; Wagner M; Fortea J; Keogh MJ; Blennow K; Skoog I; Friese MA; Pletnikova O; Zulaica M; Lage C; de Rojas I; Riedel-Heller S; Illán-Gala I; Wei W; Jeune B; Orellana A; Then Bergh F; Wang X; Hulsman M; Beker N; Tesi N; Morris CM; Indakoetxea B; Collij LE; Scherer M; Morenas-Rodríguez E; Ironside JW; van Berckel BNM; Alcolea D; Wiendl H; Strickland SL; Pastor P; Rodríguez Rodríguez E; ; ; ; ; ; ; Boeve BF; Petersen RC; Ferman TJ; van Gerpen JA; Reinders MJT; Uitti RJ; Tárraga L; Maier W; Dols-Icardo O; Kawalia A; Dalmasso MC; Boada M; Zettl UK; van Schoor NM; Beekman M; Allen M; Masliah E; de Munain AL; Pantelyat A; Wszolek ZK; Ross OA; Dickson DW; Graff-Radford NR; Knopman D; Rademakers R; Lemstra AW; Pijnenburg YAL; Scheltens P; Gasser T; Chinnery PF; Hemmer B; Huisman MA; Troncoso J; Moreno F; Nohr EA; Sørensen TIA; Heutink P; Sánchez-Juan P; Posthuma D; ; Clarimón J; Christensen K; Ertekin-Taner N; Scholz SW; Ramirez A; Ruiz A; Slagboom E; van der Flier WM; Holstege H
    Acta Neuropathol; 2019 Aug; 138(2):237-250. PubMed ID: 31131421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic correlation and gene-based pleiotropy analysis for four major neurodegenerative diseases with summary statistics.
    Qiao J; Wang T; Shao Z; Zhu Y; Zhang M; Huang S; Zeng P
    Neurobiol Aging; 2023 Apr; 124():117-128. PubMed ID: 36740554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene discovery and validation for neurodegenerative diseases.
    Mathisen PM
    Drug Discov Today; 2003 Jan; 8(1):39-46. PubMed ID: 12546990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study.
    Tang C; Lei X; Ding Y; Yang S; Ma Y; He D
    Front Immunol; 2024; 15():1339649. PubMed ID: 38348026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood.
    Ou YN; Yang YX; Deng YT; Zhang C; Hu H; Wu BS; Liu Y; Wang YJ; Zhu Y; Suckling J; Tan L; Yu JT
    Mol Psychiatry; 2021 Oct; 26(10):6065-6073. PubMed ID: 34381170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards unveiling the genetics of neurodegenerative diseases.
    Lill CM; Bertram L
    Semin Neurol; 2011 Nov; 31(5):531-41. PubMed ID: 22266890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying novel genes for amyotrophic lateral sclerosis by integrating human brain proteomes with genome-wide association data.
    Gu XJ; Su WM; Dou M; Jiang Z; Duan QQ; Wang H; Ren YL; Cao B; Wang Y; Chen YP
    J Neurol; 2023 Aug; 270(8):4013-4023. PubMed ID: 37148340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics of neurodegenerative diseases: analysis of human post-mortem brain.
    Li KW; Ganz AB; Smit AB
    J Neurochem; 2019 Nov; 151(4):435-445. PubMed ID: 30289976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
    Cheng JY; Deng YT; Yu JT
    J Neurochem; 2023 Sep; 166(6):972-981. PubMed ID: 37565992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.